explore -WSS

explore

author：Wikipedia 2025-10-03 00:40:39 - browse：1

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Cassava Sciences’ Alzheimer’s clinical trials should be halted

focus

WSS

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

How faith leaders like me can help address America's obesity epidemic

Roche acquires Telavant from Roivant, adding experimental IBD treatment

UnitedHealth, Optum discontinue NaviHealth name

Roche drug slashes death risk in early

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

CZI to create biohub to build anti

Guidelines to prevent youth baseball injuries need more muscle

Teladoc has a new CEO, but challenges remain the same

DIEP, the 'gold standard' of breast reconstruction, is under threat

New report analyzes digital physical therapy solutions' effectiveness

Medicare proposal to cover medical devices draws a mixed reaction

Coercive sterilizations revealed by STAT prompt outrage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Teladoc has a new CEO, but challenges remain the same

hotspot

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Cassava Sciences’ Alzheimer’s clinical trials should be halted

J&J lung cancer data amount to new salvo against AstraZeneca

STAT Summit: Meghan O’Rourke on making chronic illness visible

hotspot

explore

focus

focus